052260 — Hyundai BioLand Co Share Price
0.000.00%
Last trade - 00:00- KR₩116bn
- KR₩129bn
- KR₩102bn
- 69
- 59
- 37
- 58
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 0.8 | ||
| Price to Tang. Book | 0.87 | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | 0.96 | ||
| EV to EBITDA | 7.16 | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | 7.83% | ||
| Return on Equity | 5.46% | ||
| Operating Margin | 9.45% | ||
Financial Summary
| Year End 31st Dec | Unit | 2019 | 2020 | 2021 | 2022 | 2023 | 2024E | 2025E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | KR₩m | 106,310.86 | 88,898.82 | 102,801.83 | 99,153.53 | 101,690.82 | n/a | n/a | 0.22% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | -28.47 | n/a | n/a | +26.48 | -10.7 | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Hyundai Bioland Co Ltd, formerly SK Bio Land Co Ltd, is a Korea-based company mainly engaged in the development and manufacture of raw materials for cosmetics. The Company operates its business through four segments. The Cosmetic Raw Material segment produces products such as portulaca extracts, ulmus extracts, crinum extracts, hyaluronic acids and arbutins. The Pharmaceutical Ingredient segment manufactures and sells products such as phellodendron extracts, ampelopsis extracts and gardenia extracts and others. The Ingredients for Health Functional Food segment produces and distributes red ginseng extract powders, seaweed powders, glucosamine powders, black garlic extract powders, dandelion extract powders, green tea extracts and others. The Medical Device segment involves in the provision of medical equipment such as tissue engineering products, comprised of biological wound dressings and collagen, as well as diagnostic kits, comprised of rapid kits, serological kits and mask packs.
Directors
- Last Annual
- December 31st, 2023
- Last Interim
- September 30th, 2024
- Incorporated
- September 1st, 1995
- Public Since
- May 17th, 2001
- No. of Shareholders
- 27,802
- No. of Employees
- 258
- Sector
- Personal & Household Products & Services
- Industry
- Consumer Defensives
- Exchange
- Korea Exchange - KOSDAQ
- Shares in Issue
- 30,000,000
- Address
- 59, Songjeongni 2-Gil, CHEONGJU, 28162
- Web
- https://www.hyundaibioland.co.kr/main
- Phone
- +82 432496720
- Auditors
- Samil Accounting Corp.
Upcoming Events for 052260
Hyundai BioLand Co Ltd Annual Shareholders Meeting
Q1 2025 Hyundai BioLand Co Ltd Earnings Release
Similar to 052260
Ark Solutions
Korea Exchange - KOSDAQ
Barunson Co
Korea Exchange - KOSDAQ
Bbia Co
Korea Exchange - KOSDAQ
BeautySkin Co
Korea Exchange - KOSDAQ
Bonne Co
Korea Exchange - KOSDAQ
FAQ
What is the Hyundai BioLand Co share price?
As of Today at 20:12 UTC, shares in Hyundai BioLand Co are trading at KR₩3,870. This share price information is delayed by 15 minutes.
How has the Hyundai BioLand Co share price performed this year?
Shares in Hyundai BioLand Co last closed at KR₩3,870 and the price had moved by -22.2% over the past 365 days. In terms of relative price strength the Hyundai BioLand Co share price has underperformed the FTSE Developed Asia Pacific Index by -26.08% over the past year.
What are the analyst and broker recommendations for Hyundai BioLand Co?
The overall consensus recommendation for Hyundai BioLand Co is Buy. You can view the full broker recommendation list by unlocking its StockReport.
Find out moreWhat is the Hyundai BioLand Co dividend yield?
The Hyundai BioLand Co dividend yield is 0.9% based on the trailing twelve month period.
Does Hyundai BioLand Co pay a dividend?
Last year, Hyundai BioLand Co paid a total dividend of KR₩35, and it currently has a trailing dividend yield of 0.9%. We do not have any data on when Hyundai BioLand Co is to next pay dividends.
When does Hyundai BioLand Co next pay dividends?
We do not have data on when Hyundai BioLand Co is to next pay dividends. The historic dividend yield on Hyundai BioLand Co shares is currently 0.9%.
How do I buy Hyundai BioLand Co shares?
To buy shares in Hyundai BioLand Co you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of Hyundai BioLand Co?
As of the previous close price of KR₩3,870, shares in Hyundai BioLand Co had a market capitalisation of KR₩116bn.
Where are Hyundai BioLand Co shares listed?
Here are the trading details for Hyundai BioLand Co:
- Country of listing: Korea, Republic of
- Exchange: KOE
- Ticker Symbol: 052260
What kind of share is Hyundai BioLand Co?
Based on an overall assessment of its quality, value and momentum Hyundai BioLand Co is currently classified as a Neutral. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a Hyundai BioLand Co share price forecast for 2024?
The analyst consensus target price for shares in Hyundai BioLand Co is KR₩20,000. That is 416.8% above the last closing price of KR₩3,870.
Analysts covering Hyundai BioLand Co currently have a consensus Earnings Per Share (EPS) forecast of for the next financial year.
Find out moreWhat is the trend in the Hyundai BioLand Co share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Hyundai BioLand Co. Over the past six months, its share price has underperformed the FTSE Developed Asia Pacific Index by -30.8%.
As of the last closing price of KR₩3,870, shares in Hyundai BioLand Co were trading -23.86% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the Hyundai BioLand Co PE Ratio?
The Hyundai BioLand Co PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at KR₩3,870.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of Hyundai BioLand Co?
Hyundai BioLand Co's management team is headed by:
- Chan Bok Jung - CEO
- Yin Guk Yim - VPR
- Taek Seon Lee - DRC